Skip to main content

Table 3 Comparative cost analysis for clinical management of COVID-19 case with and without underlying diseases

From: Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis

Classification Cost per case (USD, Mean ± SD) P value
Without underlying diseases With underlying diseases
Laboratory diagnostics 948 ± 536 1595 ± 856 0.001
Radiologic diagnostics 216 ± 124 332 ± 172 0.001
Therapeutic measures 951 ± 920 2882 ± 2940 0.001
Drug acquisition 1375 ± 1832 4511 ± 4937 < 0.001
Bed costs 129 ± 53 208 ± 127 0.003
Total 3619 ± 3243 9525 ± 8592 0.001